AirNexis Therapeutics News and Activities

AirNexis Therapeutics is owned by Frazier Healthcare Partners.

Frazier Healthcare Partners has 9 subsidiaries including AirNexis Therapeutics, Altruix and Comprehensive Pharmacy Services.

They are in:

• Healthcare30%
• Fund20%
• Other50%

Acquisition, funding and merger involving Frazier Healthcare Partners.

• AirNexis Therapeutics has just announced a $200 Million fundraising (posted on February 1 2026).

View the org chart displaying its 6 main executives

Most searched biographies at AirNexis Therapeutics

• Maria Fardis, Chief Executive Officer
• Jill Carroll, Director
• Evan Caplan, Director

Create your alert
to follow the executive moves at AirNexis Therapeutics.

Frazier Healthcare Partners has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by AirNexis Therapeutics

Social media about AirNexis Therapeutics

• AirNexis Therapeutics on Wikipedia, Google News & Yahoo Finance
• AirNexis Therapeutics on LinkedIn, X (Twitter) & YouTube